Skip to main content

Liu Lab has published a new article in Circulation, “Lin28a Regulates Pathological Cardiac Hypertrophic Growth through Pck2-Mediated Enhancement of Anabolic Synthesis.” This research is featured in Vital Signs, which points out that the study’s discovery that RNA-binding protein Lin28a is needed for the development of pathological hypertrophy may have considerable impact on the development of more potent therapeutics for the treatment of heart disease